Dopamine Oxidation and Autophagy
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms involved in the neurodegenerative process of Parkinson's disease remain unclear. Currently, there is a general agreement that mitochondrial dysfunction, α -synuclein aggregation, oxidative stress, neuroinflammation, and impaired protein degradation are involved in the neurodegeneration of dopaminergic neurons containing neuromelanin in Parkinson's disease. Aminochrome has been proposed to play an essential role in the degeneration of dopaminergic neurons containing neuromelanin by inducing mitochondrial dysfunction, oxidative stress, the formation of neurotoxic α -synuclein protofibrils, and impaired protein degradation. Here, we discuss the relationship between the oxidation of dopamine to aminochrome, the precursor of neuromelanin, autophagy dysfunction in dopaminergic neurons containing neuromelanin, and the role of dopamine oxidation to aminochrome in autophagy dysfunction in dopaminergic neurons. Aminochrome induces the following: (i) the formation of α -synuclein protofibrils that inactivate chaperone-mediated autophagy; (ii) the formation of adducts with α - and β -tubulin, which induce the aggregation of the microtubules required for the fusion of autophagy vacuoles and lysosomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








![Figure 9 The effects of aminochrome on β-tubulin (a–d) and the accumulation of autophagosomes in the cytosol of cells treated with aminochrome (e). RCSN-3 cells were treated with cell culture medium (a), 100 μM dicoumarol (b), 50 μM aminochrome (c), and 50 μM aminochrome and 100 μM dicoumarol (d) and incubated for 48 h as described by Paris et al. 2010 [15]. In (e) the number of autophagosomes per cell was determined by incubating RCSN3 cells for 24 h with cell culture medium (Co), 100 μM dicoumarol (Di), 10 μM vinblastine (V), 20 μM aminochrome (AM), 20 μM aminochrome and 100 μM dicoumarol (AMDi), 20 μM aminochrome and 100 μM dicoumarol and 10 μM vinblastine (AMDiV). As a positive control, cells were incubated with cell culture medium without bovine serum (Co+). The statistical significance was assessed using ANOVA for multiple comparisons and Student's t test (***P < 0.001). This experiment was performed as described by Paris et al. 2011 [40].](https://figures.cochat.ai/paper-figures/6606d0df62c94c54aa8f4a98cd3360a9/dopamine-oxidation-and-autophagy-figure-9.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Further self-amplification would come from the facts that dopamine autooxidizes to give O2•− (219) and ONOO– also oxidizes dopamine (220).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“In familiar PD, the formation of neurotoxic α-synuclein protofibers is dependent on a specific point mutation [33].”
BackgroundParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026 · cited 1×
“Parkin has also been shown to promote autophagy of damaged mitochondria by relocalizing into dysfunctional mitochondria with low membrane potentials in mammalian cells [68].”
BackgroundImpaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Interestingly, the pathogenic A53T and A30P α-synuclein mutants inhibit their own degradation and that of other substrates [64].”
BackgroundKinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Epidemiology of Alzheimer Disease
Mayeux, R., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,064
GRAHAM, D. G., TIFFANY, S. M., BELL, W. R., & GUTKNECHT, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953
α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003122 · Cited by 825 · cited 1×
“α-synuclein impairs autophagy via Rab1a inhibition, and Rab1a overexpression rescues the autophagy defect caused by α-synuclein [66].”
BackgroundDopamine covalently modifies and functionally inactivates parkin
LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722 · cited 1×
“of the proteasomal system, by forming adducts with parkin [14] as well as inhibit the proteasome [76].”
BackgroundVogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801992200 · Cited by 683 · cited 1×
“Wild-type α-synuclein is degraded by chaperonemediated autophagy (CMA) and macroautophagy because the inhibition of CMA and macroautophagy lead to accumulation of wild type α-synuclein [62].”
BackgroundRole of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells
Plowey, E. D., Cherra, S. J., Liu, Y., & Chu, C. T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05217.x · Cited by 493 · cited 1×
“Transfection of the common G2019S LRRK2 mutation into SH-SY5Y cells was reported to increase autophagy in both neuritic and somatic compartments [70].”
Background
Research works printed but not linked: 5
- 1995, Biometals, 25, 795
- 2006, Society for Neuroscience, 824, article 17
- 2008, Neurotoxicity Research, 13, article 136
- 1984, Journal of Chromatography, 311, 154
- 2012, Cold Spring Harbor Perspectives in Medicine, 2, 1
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
“This reaction is catalyzed by metals, oxygen or enzymes such as tyrosinase [47].”
BackgroundOxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
“…tion of proteins, especially thiol groups of cysteine residues (Eaton, 2006), which act as a redox switch by altering physiological pro‐ tein functions, promoting alternative protein functions, or facilitat‐ ing secondary interactions (D'Autreaux & Toledano, 2007; Eaton, 2006; Murphy, 2009).”
BackgroundOxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
“…in SNpc. Dopamine also undergoes auto-oxidation that is catalyzed by metals or enzymes such as tyrosinase, resulting in the formation of dopamine quinones [108], which cyclize to form aminochrome, a highly reactive compound capable of generating superoxide and depleting cellular NADPH stores [109].”
Complexity of dopamine metabolism
Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 663
“CAs can be enzymatically oxidized by cyclooxygenases (COX, prostaglandin H synthase), tyrosinase and other enzymes [149,150].”
BackgroundInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
“…et al., 2014; Zafar et al., 2006; Zhou and Lim, 2009), inhibition of the fusion of autophagic vacuoles with lysosomes (Huenchuguala et al., 2014; Muñoz et al., 2012a; Paris et al., 2010), and lysosomal dysfunction (Huenchuguala et al., 2014) in rat and human cell lines; (iii) oxidative stress…”
InfluentialSelf-citationDopamine in Parkinson's disease
Latif, S., Jahangeer, M., Maknoon Razia, D., Ashiq, M., Ghaffar, A., Akram, M., El Allam, A., Bouyahya, A., Garipova, L., Ali Shariati, M., et al. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.08.009 · Cited by 340
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338
“DA-modified α -syn leads to cellular toxicity and autophagy dysfunction 42,43 .”
Role of dopamine in the pathophysiology of Parkinson’s disease
Zhou, Z. D., Yi, L. X., Wang, D. Q., Lim, T. M., & Tan, E. K. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00378-6 · Cited by 308
“Furthermore, DAQs can directly conjugate with α-syn to induce the formation of toxic α-syn protofibrils, leading to inactivation of the chaperone-mediated autophagy [62].”
BackgroundOxidative stress factors in Parkinson’s disease
Dorszewska, J., Kowalska, M., Prendecki, M., Piekut, T., Kozłowska, J., & Kozubski, W. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.300980 · Cited by 210
“The toxic DA-quinone is further metabolized to aminochrome, a metabolite that was shown to induce formation of ASN aggregates (Muñoz et al., 2012).”
BackgroundDopamine in Health and Disease: Much More Than a Neurotransmitter
Franco, R., Reyes-Resina, I., & Navarro, G. (2021) · Biomedicines · doi:10.3390/biomedicines9020109 · Cited by 199
Mechanistic insights into the electrochemical oxidation of dopamine by cyclic voltammetry
Schindler, S., & Bechtold, T. (2019) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2019.01.069 · Cited by 159
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
“Moreover, both DA and its metabolite 3,4-dihydroxyphenylacetaldehyde can undergo autooxidation to form superoxide and reactive semiquinones (LaVoie and Hastings, 1999; Sulzer and Zecca, 2000; Anderson et al., 2011; Munoz et al., 2012).”
BackgroundDerry, P. J., Hegde, M. L., Jackson, G. R., Kayed, R., Tour, J. M., Tsai, A.-L., & Kent, T. A. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101716 · Cited by 140
“Dioxygen finally oxidizes the 5,6dihydroxyindole to 5,6-indolequinone which polymerizes to form neuromelanin (Munoz et al., 2012).”
BackgroundImmunomodulatory Effects Mediated by Dopamine
Arreola, R., Álvarez-Herrera, S., Pérez‐Sánchez, G., Becerril‐Villanueva, E., Cruz-Fuentes, C. S., Flores-Gutiérrez, E. O., Garcés-Alvarez, M. E., de la Cruz-Aguilera, D. L., Medina‐Rivero, E., Hurtado‐Alvarado, G., et al. (2016) · Journal of Immunology Research · doi:10.1155/2016/3160486 · Cited by 153
“In Parkinson disease, excess production and accumulation of DA and its catabolites in the cytosol can effect mitochondrial dysfunction, oxidative stress, the formation of neurotoxic α-synuclein protofibrils, and impairments in protein degradation, which mediate the neurodegeneration of dopaminergic neurons in Parkinso…”
Herrera, A., Muñoz, P., Steinbusch, H. W. M., & Segura-Aguilar, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00034 · Cited by 135
Self-citationImpact of Dopamine Oxidation on Dopaminergic Neurodegeneration
Zhang, S., Wang, R., & Wang, G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00454 · Cited by 141
Neuromelanin, one of the most overlooked molecules in modern medicine, is not a spectator
Haining, R., & Achat-Mendes, C. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.202928 · Cited by 116
“When dopamine is oxidized to dopamine o-quinone, aminochrome and 5,6-in-dolequinone are formed and typically undergo polymerization to form the dark pigment, neuromelanin (Munoz et al., 2012).”
BackgroundRecent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration
Niranjan, R. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.003 · Cited by 123
“Under normal conditions basal autophagy is a mechanism responsible for the elimination of damaged or aged organelles and cytoplasmic components to maintain cell homeostasis; however, extensive autophagy or inappropriate activation of autophagy results in cell death (Altman and Rathmell, 2009; Munoz et al., 2012).”
BackgroundIova, O.-M., Marin, G.-E., Lazar, I., Stănescu, I., Dogaru, G., Nicula, C. A., & Bulboacă, A. E. (2023) · Antioxidants · doi:10.3390/antiox12030753 · Cited by 138
Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease
Khalifeh, M., Barreto, G. E., & Sahebkar, A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14623 · Cited by 113
Berríos‐Cárcamo, P., Quezada, M., Quintanilla, M. E., Morales, P., Ezquer, M., Herrera‐Marschitz, M., Israel, Y., & Ezquer, F. E. (2020) · Antioxidants · doi:10.3390/antiox9090830 · Cited by 121
Automated microfluidic cell culture of stem cell derived dopaminergic neurons
Kane, K. I. W., Moreno, E. L., Hachi, S., Walter, M., Jarazo, J., Oliveira, M. A. P., Hankemeier, T., Vulto, P., Schwamborn, J. C., Thoma, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-34828-3 · Cited by 105
Vidoni, C., Secomandi, E., Castiglioni, A., Melone, M. A. B., & Isidoro, C. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.013 · Cited by 104
“Given the role of microtubules in the autophagosome-lysosome fusion process (K€ochl et al., 2006), it is likely that DA quinones may cause an impairement of the autophagy flux (Mu~noz et al., 2012).”
Molecular Effects of L-dopa Therapy in Parkinson’s Disease
Dorszewska, J., Prendecki, M., Lianeri, M., & Kozubski, W. (2014) · Current Genomics · doi:10.2174/1389202914666131210213042 · Cited by 95
“Another process probably leading to cell death in PD is autophagy [12, 13].”
BackgroundInfluentialWise, R. M., Wagener, A., Fietzek, U. M., Klopstock, T., Mosharov, E. V., Zucca, F. A., Sulzer, D., Zecca, L., & Burbulla, L. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105920 · Cited by 99
“…stable in the cytosol at physiological pH and therefore undergo modifications into more stable forms (i.e., 5,6-dihydroxyindole, 5,6-indolequinone) and finally polymerize forming adducts with proteins and leading to the synthesis of the dark NM pigment (Ferrari et al., 2017; Munoz et al., 2012).”
BackgroundAntiferroptotic activity of non-oxidative dopamine
Wang, D., Peng, Y., Xie, Y., Zhou, B., Sun, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.099 · Cited by 91
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
Barba, L., Paoletti, F. P., Bellomo, G., Gaetani, L., Halbgebauer, S., Oeckl, P., Otto, M., & Parnetti, L. (2022) · Movement Disorders · doi:10.1002/mds.28941 · Cited by 92
“Inside presynaptic vesicles, DA colocalizes with antioxidants,(37) while free cytosolic DA can undergo oxidative reactions that release toxic DA-derived compounds, such as DA–quinone, aminochrome, and 5,6-indole–quinone.(38) Some of these products can even interact with β-synuclein and promote its aggregation.”
BackgroundAhmadi, N., Bagherzadeh, M., & Nemati, A. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111977 · Cited by 84
Mitochondrial control of cell bioenergetics in Parkinson’s disease
Requejo-Aguilar, R., & Bolaños, J. P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.012 · Cited by 95
DT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity
Muñoz, P., Cardenas, S., Huenchuguala, S., Briceño, A., Couve, E., Paris, I., & Segura-Aguilar, J. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv016 · Cited by 79
“…I by aminochrome (Aguirre et al., 2012); protein degradation dysfunction by inhibiting autophagy/lysosomal system (Huenchuguala et al., 2014; Muñoz et al., 2012), as a consequence of a- and b-tubulin aggregation induced by aminochrome preventing microtubules formation (Paris et al., 2010),…”
BackgroundResultInfluentialSelf-citationNeurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update
Segura‐Aguilar, J., & Kostrzewa, R. M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9519-y · Cited by 81
“DT-diaphorase prevents mitochondria dysfunction (Fuentes et al. 2007; Paris et al. 2011; Arriagada et al. 2004; Muñoz et al. 2012c); prevents formation of a-synuclein oligomers (Cardenas et al. 2008); inhibits the proteasome system (Zafar et al. 2006; Xiong et al. 2014); inhibits autophagy (Muñoz…”
BackgroundInfluentialSelf-citationDefective Autophagy in Parkinson’s Disease: Lessons from Genetics
Zhang, H., Duan, C., & Yang, H. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8787-5 · Cited by 79
“Aminochromes, the products of DA oxidation in the cytosol, were reported to form adducts with α-synuclein by binding the 125YEMPS129 motif and to generate and stabilize αsynuclein protofibrils [37].”
BackgroundAchour, I., Arel-Dubeau, A.-M., Renaud, J., Legrand, M., Attard, E., Germain, M., & Martinoli, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081293 · Cited by 69
Guan, H., Yang, H., Yang, M., Yanagisawa, D., Bellier, J., Mori, M., Takahata, S., Nonaka, T., Zhao, S., & Tooyama, I. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.02.001 · Cited by 66
“In addition, dopamine is an unstable molecule and it may be vulnerable to auto-oxidation (Dias et al., 2013; Muñoz et al., 2012).”
Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease
Dorszewska, J., Prendecki, M., Oczkowska, A., Różycka, A., Lianeri, M., & Kozubski, W. P. (2014) · Current Genomics · doi:10.2174/1389202914666131210210241 · Cited by 61
“This reaction requires Sadenosylmethionine (SAM) as a co-substrate to provide methyl groups [26].”
BackgroundMp TCP 1 controls cell proliferation and redox processes in Marchantia polymorpha
Busch, A. E., Deckena, M., Almeida-Trapp, M., Kopischke, S., Kock, C., Schüßler, E., Tsiantis, M., Mithöfer, A., & Zachgo, S. (2019) · New Phytologist · doi:10.1111/nph.16132 · Cited by 59
“Thus, MpTCP1 represses the synthesis of ac and its derivatives, which have known functions in the formation of neuromelanine in animals (Munoz et al., 2012), but to date no function has been described for these compounds in plants.”
BackgroundCuevas, C. M., Huenchuguala, S., Muñoz, P., Villa, M., Paris, I. B., Mannervik, B., & Segura‐Aguilar, J. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9500-1 · Cited by 53
“…system including mitochondrial dysfunction, protein degradation dysfunction, aggregation of alpha-synuclein to toxic protofibrils, and oxidative stress (Huenchuguala et al. 2014; Segura-Aguilar et al. 2014; Norris et al. 2005; Zafar et al. 2006; Muñoz et al. 2012a, b; Aguirre et al. 2012).”
Self-citationInteraction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
Xu, S., & Chan, P. (2015) · Biomolecules · doi:10.3390/biom5021122 · Cited by 60
“NM accumulates in double membrane autophagic vacuoles, preventing neurotoxic effects of free neuromelanin in cells exposed to this pigment [27].”
BackgroundNeuronal Oxidative Stress Promotes α-Synuclein Aggregation In Vivo
Won, S. J., Fong, R., Butler, N. J. M., Sanchez, J., Zhang, Y., Wong, C., Nzoutchoum, O. T., Huynh, A., Pan, J., & Swanson, R. A. (2022) · Antioxidants · doi:10.3390/antiox11122466 · Cited by 55
Back, M. J., Ha, H. C., Fu, Z., Choi, J. M., Piao, Y., Won, J. H., Jang, J. M., Shin, I. C., & Kim, D. K. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0709-4 · Cited by 51
Risk of defeats in the central nervous system during deep space missions
Kokhan, V. S., Матвеева, М. И., Mukhametov, A., & Shtemberg, A. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.006 · Cited by 49
“The key issue is that dopamine easily oxidizes, forming many toxic products: DHBT-1 and other benzothiazines (Li and Dryhurst, 1997; Magnay et al., 2001), leykoaminohrom-o-semiquinone and products of its conjugation (Munoz et al., 2012).”
BackgroundPradhan, P., Majhi, O., Biswas, A., Joshi, V. K., & Sinha, D. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02942-8 · Cited by 44
Özel, R. E., Hayat, A., & Andreescu, S. (2014) · Analytical Letters · doi:10.1080/00032719.2014.976867 · Cited by 47
“Dopamine plays a vital role in the control of movements and has been associated with the motor symptoms experienced in patients with Parkinson’s disease (Munoz et al. 2012).”
BackgroundAminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson’s disease
Herrera, A., Muñoz, P., Paris, I. B., Díaz‐Véliz, G., Mora, S., Inzunza, J., Hultenby, K. R., Cárdenas, C., Jaña, F., Raisman‐Vozari, R., et al. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2182-5 · Cited by 44
Self-citationArel-Dubeau, A.-M., Longpré, F., Bournival, J., Tremblay, C., Demers-Lamarche, J., Hašková, P., Attard, E., Germain, M., & Martinoli, M. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/425496 · Cited by 47
“To further study the antioxidant potential of CuE, we used MitoSOX Red to measure its ability to quench ROS generated by the inhibition of superoxide dismutase (SOD) (Figures 5(a) and 5(b)).”
InfluentialMinta, D., González, Z., Wiench, P., Gryglewicz, S., & Gryglewicz, G. (2020) · Sensors · doi:10.3390/s20164427 · Cited by 43
Engineering injectable, biocompatible, and highly elastic bioadhesive cryogels
Rana, D., Colombani, T., Saleh, B., Mohammed, H. S., Annabi, N., & Bencherif, S. A. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100572 · Cited by 47
“These binding sites are typically consumed during the unwanted oxidation-mediated polymerization of DOPA into PDA [60 – 63].”
Opposed Effects of Dityrosine Formation in Soluble and Aggregated α-Synuclein on Fibril Growth
Wördehoff, M. M., Shaykhalishahi, H., Groß, L., Gremer, L., Stoldt, M., Buell, A. K., Willbold, D., & Hoyer, W. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.005 · Cited by 44
“First, its high dopamine content is a source of reactive oxygen species (ROS), as the deamination of dopamine by monoamine oxidase generates H2O2, which is a strong oxidizing agent [15].”
Graphene quantum dots for ultrasensitive detection of acetylcholinesterase and its inhibitors
Li, N., Wang, X., Chen, J., Sun, L., & Chen, P. (2015) · 2D Materials · doi:10.1088/2053-1583/2/3/034018 · Cited by 41
“The autoxidation of dopamine produces quinone (Q), semiquinone (•QH), and reactive oxygen species [39].”
Shaw, W. (2017) · Europe PMC (PubMed Central) · Cited by 46
Lee, D.-Y., Park, M., Kim, N., Gu, M., Kim, H., & Kim, B. (2022) · Journal of Catalysis · doi:10.1016/j.jcat.2022.05.017 · Cited by 41
On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease
Segura‐Aguilar, J. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.208560 · Cited by 40
“…Segura-Aguilar et al., 1998; Arriagada et al., 2004; Zafar et al., 2006; Fuentes et al., 2007; Paris et al., 2010, 2012; Aguirre et al., 2012; Muñoz et al., 2012a, b, 2015; Huenchuguala et al., 2014; Xiong et al., 2014; Briceño et al., 2015; Muñoz and Segura-Aguilar, 2017b; Santos et al.,…”
BackgroundSelf-citationNanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes
Padilla-Godínez, F. J., Ruiz-Ortega, L. I., & Guerra‐Crespo, M. (2022) · Cells · doi:10.3390/cells11213445 · Cited by 41
Recent Progress in Autocatalytic Ceria Nanoparticles-Based Translational Research on Brain Diseases
Choi, S. W., & Kim, J. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b02243 · Cited by 41
Huenchuguala, S., Muñoz, P., & Segura‐Aguilar, J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00152 · Cited by 39
Self-citationChumarina, M., Russ, K., Azevedo, C., Heuer, A., Pihl, M., Collin, A., Frostner, E. Å., Elmér, E., Hyttel, P., Cappelletti, G., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0863-7 · Cited by 43
“Primary antibodies were diluted in blocking solution and incubated overnight at 4 °C: mouse anti-AFP (Sigma-Aldrich, A8452, 1: 500), mouse anti-SMA (Sigma-Aldrich, A2547, 1:500), rabbit anti-TUJ1 (Covance, PRB-435P, 1:500), mouse anti-Oct4 (Millipore, MAB4401, 1:200), mouse antiNanog (BD Biosciences, 560,483, 1:200),…”
BackgroundInfluentialvan der Vlag, M., Havekes, R., & Heckman, P. R. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14689 · Cited by 38
“…their own, aminochrome can form adducts with several proteins implicated in PD, including Parkin (LaVoie, Ostaszewski, Weihofen, Schlossmacher, & Selkoe, 2005), DAT (Whitehead, Ferrer, Javitch, & Justice, 2001) and perhaps, most interestingly, α-syn (Chen & Saez-Atienzar, 2018; Muñoz et al., 2012).”
BackgroundTorrens-Spence, M. P., Liu, C., Pluskal, T., Chung, Y. K., & Weng, J. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00821 · Cited by 37
Single-neuron neurodegeneration as a degenerative model for Parkinson’s disease
Huenchuguala, S., & Segura‐Aguilar, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380878 · Cited by 37
“…as endoplasmic reticulum and oxidative stress, neuroinflammation, and the formation of neurotoxic oligomers of SNCA (Arriagada et al., 2004; Zafar et al., 2006; Paris et al., 2011; Aguirre et al., 2012; Muñoz et al., 2012a; Huenchuguala et al., 2014, 2017; Xiong et al., 2014; Santos et al., 2017).”
BackgroundSelf-citationAminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures
de Araújo, F. M., Ferreira, R. S., Souza, C. D. S., dos Santos, C. C., Rodrigues, T. L. R. S., Silva, J. H. C. E., Gasparotto, J., Gelain, D. P., El-Bachá, R. D. S., Costa, M. D. F. D., et al. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.03.009 · Cited by 34
“…et al., 2015; Norris et al., 2005; Aguirre et al., 2012; Arriagada et al., 2004; Briceño et al., 2016; Cuevas et al., 2015; Huenchuguala et al., 2014; Muñoz et al., 2012a, b; Paris et al., 2011; Segura-aguilar and Kostrzewa, 2015; Xiong et al., 2014; Zafar et al., 2006; Segura-Aguilar, 2017).”
BackgroundSelf-citationBadillo‐Ramírez, I., Saniger, J. M., & Rivas-Arancibia, S. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104514 · Cited by 36
Limanaqi, F., Busceti, C. L., Celli, R., Biagioni, F., & Fornai, F. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102112 · Cited by 45
“4, Muñoz et al., 2012; da Luz et al., 2015; He et al., 2018; Kang et al., 2020).”
BackgroundPathogenesis of Parkinson’s Disease
Xiao, B., Zhou, Z., Chao, Y., & Tan, E.-K. (2025) · Neurologic Clinics · doi:10.1016/j.ncl.2024.12.003 · Cited by 76
A Druglike Ferrostatin‐1 Analogue as a Ferroptosis Inhibitor and Photoluminescent Indicator
Yan, J., Bao, L., Liang, H., Zhao, L., Liu, M., Kong, L., Fan, X., Liang, C., Liu, T., Han, X., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202502195 · Cited by 41
Neuroprotective Investigation of Chitosan Nanoparticles for Dopamine Delivery
Ragusa, A., Priore, P., Giudetti, A. M., Ciccarella, G., & Gaballo, A. (2018) · Applied Sciences · doi:10.3390/app8040474 · Cited by 34
“Moreover, DA is also easily metabolized by monoamine oxidase (MAO) to 3,4-dihydroxyphenylacetic acid with the concomitant formation of hydrogen peroxide [24].”
BackgroundDiaz, M. R., Jotty, K., Locke, J. L., Jones, S. R., & Valenzuela, C. F. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00046 · Cited by 32
“After release, DA is taken up into the terminal where it can be degraded by monoamine oxidase (MAO) to produce DOPAC, which can be further catalyzed by catechol-Omethyltransferase (COMT) into HVA [Figure 5A; also reviewed by (49)].”
BackgroundKokhan, V. S., Матвеева, М. И., Bazyan, A. S., Кудрин, В. С., Mukhametov, A., & Shtemberg, A. S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.032 · Cited by 33
Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase
Segura‐Aguilar, J., Muñoz, P., Inzunza, J., Varshney, M., Nalvarte, I., & Mannervik, B. (2022) · Antioxidants · doi:10.3390/antiox11020296 · Cited by 33
“These data suggest that 5-cysteinyldopamine is a final product, supporting the notion that GST M2-2 is a neuroprotective enzyme against aminochrome neurotoxicity [81] (Figure 4).”
BackgroundResultSelf-citationAberrant Autophagy and Parkinsonism: Does Correction Rescue from Disease Progression?
Mishra, A. K., Rasheed, M. S. U., Shukla, S., Tripathi, M. K., Dixit, A., & Singh, M. P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8744-3 · Cited by 33
“Protofibril could inactivate CMA, while adduct could induce aggregation of the microtubules required for the fusion of autophagosome to the lysosome [40].”
DT-diaphorase protects astrocytes from aminochrome-induced toxicity
Huenchuguala, S., Muñoz, P., Graumann, R., Paris, I. B., & Segura‐Aguilar, J. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.04.014 · Cited by 30
“…et al., 2015), (ii) dysfunction of protein degradation in both the proteasomal and lysosomal systems (Zafar et al., 2006; Huenchuguala et al., 2014; Muñoz et al., 2012a), (iii) mitochondrial dysfunction (Aguirre et al., 2012; Muñoz et al., 2012b; Arriagada et al., 2004), (iv) oxidative stress…”
BackgroundSelf-citationJaramillo, A. M., Barrera-Gutiérrez, R., & Cortés, M. T. (2020) · ACS Omega · doi:10.1021/acsomega.0c00676 · Cited by 31
Hormone-linked redox status and its modulation by antioxidants
Sahoo, D. K., & Chainy, G. B. N. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2022.10.007 · Cited by 39
Franco, R., Rivas‐Santisteban, R., Navarro, G., Pinna, A., & Reyes‐Resina, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094643 · Cited by 33
“The reaction of dopamine with molecular oxygen can lead to other quinones and free radicals, an oxidative load that alters mitochondrial function and can produce autophagy in dopaminergic neurons [168,169].”
BackgroundHörmann, P., Delcambre, S., Hanke, J. E., Geffers, R., Leist, M., & Hiller, K. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00547-4 · Cited by 36
Hopp, S. C., Royer, S. E., D’Angelo, H. M., Kaercher, R. M., Fisher, D. A., & Wenk, G. L. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9568-7 · Cited by 32
“The SN may be more resistant to treatment due to the presence of DA, which itself can exacerbate pathology via a variety of mechanisms (Muñoz et al. 2012), or due to SN iron enrichment (Zhang et al. 2014).”
Targeting redox regulation to treat substance use disorder using N‐acetylcysteine
Womersley, J. S., Townsend, D. M., Kalivas, P. W., & Uys, J. D. K. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14130 · Cited by 30
“Under such conditions, dopamine may undergo two sequential one-electron oxidation reactions to form the intermediate dopamine o-semiquinone and finally dopamine o-quinone in a process that is accompanied by the formation of two superoxide radicals (Munoz et al., 2012).”
BackgroundVano, L. J., McCutcheon, R. A., Rutigliano, G., Kaar, S. J., Finelli, V., Nordio, G., Wellby, G., Sedlacik, J., Statton, B. K., Rabiner, E. A., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.06.013 · Cited by 29
A new mechanism for protection of dopaminergic neurons mediated by astrocytes
Segura‐Aguilar, J. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.162750 · Cited by 28
“In addition, aminochrome induces protein degradation dysfunction by (i) impairing the proteasomal system; (ii) inducing lysosome dysfunction (Huenchuguala et al., 2014); and (iii) inhibiting autophagy (Muñoz et al., 2012; Huenchuguala et al., 2014).”
BackgroundSelf-citationAge-related variability in decision-making: Insights from neurochemistry
Berry, A. S., Jagust, W. J., & Hsu, M. (2018) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-018-00678-9 · Cited by 30
Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing
Artyukhova, M. A., Tyurina, Y. Y., Chu, C. T., Zharikova, T. M., Bayır, H., Kagan, V. E., & Timashev, P. S. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.007 · Cited by 27
Ilie, O., Ciobica, A. S., McKenna, J., Doroftei, B., & Mavroudis, I. A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4518023 · Cited by 33
“Dopamine (DA) (excitatory and inhibitory role of synaptic transmission) as a construct produced from DA neurons can in turn be a source of OS due to its unstable nature selectivity for SNpc (substantia nigra pars compacta) which undergoes self-oxidation in order to form dopamine quinones and free radicals, reactions c…”
BackgroundCurrent Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms
Wildburger, N. C., Hartke, A.-S., Schidlitzki, A., & Richter, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.598446 · Cited by 30
“Cytosolic DA can readily oxidize to dopaminochrome, even without the aid of metal-ion catalysis (Linert et al., 1996; Munoz et al., 2012).”
BackgroundSegura‐Aguilar, J., & Mannervik, B. (2023) · Antioxidants · doi:10.3390/antiox12030673 · Cited by 29
Self-citationMohite, G. M., Navalkar, A., Kumar, R., Mehra, S., Das, S., Gadhe, L. G., Ghosh, D., Alias, B., Chandrawanshi, V., Ramakrishnan, A., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00321 · Cited by 27
Autophagy and Redox Homeostasis in Parkinson’s: A Crucial Balancing Act
Jiménez-Moreno, N., & Lane, J. D. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8865611 · Cited by 28
“Consequently, aminochrome contributes to autophagy impairment both cell autonomously [453], and noncell autonomously via neuroinflammation, which itself is linked to glial autophagy dysfunction (e.”
BackgroundLevodopa: From Biological Significance to Continuous Monitoring
Probst, D., Batchu, K., Younce, J. R., & Sode, K. (2024) · ACS Sensors · doi:10.1021/acssensors.4c00602 · Cited by 27
Wiench, P., González, Z., Gryglewicz, S., Menéndez, R., & Gryglewicz, G. (2019) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2019.113547 · Cited by 25
A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic
Ghannoum, M. A., Ford, M., Bonomo, R. A., Gamal, A., & McCormick, T. S. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.672390 · Cited by 24
“This increase in dopamine in neurons leads to production of oxidative species, depletion of glutathione and subsequently brain damage (240, 243, 244).”
BackgroundSung, J. S., Bong, J.-H., Yun, T. G., Han, Y., Park, Y., Jung, J., Lee, S. J., Kang, M., Jose, J., Lee, M., et al. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00107 · Cited by 25
Discovery of a Gut Bacterial Metabolic Pathway that Drives α-Synuclein Aggregation
Ortiz de Ora, L., Balsamo, J. M., Uyeda, K. S., & Bess, E. N. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00095 · Cited by 24
Zhang, Q., & Gong, M. (2016) · Journal of Chromatography A · doi:10.1016/j.chroma.2016.04.080 · Cited by 23
Bandala, C., Cárdenas‐Rodríguez, N., Mendoza‐Torreblanca, J. G., Contreras‐García, I. J., Martínez-López, V., Cruz-Hernández, T. R., Carro-Rodríguez, J., Vargas-Hernández, M. A., Ignacio‐Mejía, I., Alfaro-Rodríguez, A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020693 · Cited by 24
“Finally, the ALDH enzyme catalyzes HMPAL to generate homovanillic acid (HVA), which is the main endproduct of DA degradation [20,22,23].”
BackgroundOn the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo
Herrera-Soto, A., Díaz‐Véliz, G., Mora, S., Muñoz, P., Henny, P., Steinbusch, H. W. M., & Segura‐Aguilar, J. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9719-8 · Cited by 24
Self-citationdo Carmo, D. R., & Fernandes, D. S. (2017) · Solid State Sciences · doi:10.1016/j.solidstatesciences.2017.07.005 · Cited by 22
Valdés, R., Armijo, A., Muñoz, P., Hultenby, K. R., Hagg, A., Inzunza, J., Nalvarte, I., Varshney, M., Mannervik, B., & Segura‐Aguilar, J. (2021) · Neurotoxicity Research · doi:10.1007/s12640-020-00327-5 · Cited by 22
Self-citationHuenchuguala, S., & Segura‐Aguilar, J. (2024) · Antioxidants · doi:10.3390/antiox13091125 · Cited by 28
Self-citationWulf, M., Barkovits, K., Schork, K., Eisenacher, M., Riederer, P. F., Gerlach, M., Eggers, B., & Marcus, K. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02530-4 · Cited by 23
“Conversely, MAOA showed a comparable abundance in SNSurr. tissue and NMGs (fold change: 0.83; q value: 0.18), while MAOB was significantly higher abundant in SNSurr. tissue (fold change: 0.59; q value: 0.04).”
BackgroundInfluentialTripodi, G., Lombardo, M., Kerav, S., Aiello, G., & Baldelli, S. (2025) · Nutrients · doi:10.3390/nu17030393 · Cited by 25
Barrigon, C. D. L. F., Burke, D. G., Eaton, S. D., & Heales, S. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.02.013 · Cited by 27
“damage complex I and stabilize alpha-synuclein (Aguirre et al., 2012; Munoz et al., 2012).”
Autophagy status as a gateway for stress-induced catecholamine interplay in neurodegeneration
Fornai, F., & Puglisi‐Allegra, S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.015 · Cited by 20
Metadata
- Authors
- Muñoz, P., Huenchuguala, S., Paris, I., & Segura-Aguilar, J.
- Affiliations
- University of Chile (CL)
- Universidad Santo Tomás (CL)
- Molecular & Clinical Pharmacology, ICBM, Faculty of Medicine, University of Chile, Independencia 1027, Santiago 8380453, Chile
- Venue
- Parkinson's Disease
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-13
- ISSN
- 2042-0080 (ISSN-L)
- 2090-8083
- PMC
- PMC3433151
- OpenAlex
- W2096782959
- Cited by
- 214
- References
- 75
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 9 · 2023: 20 · 2022: 25 · 2021: 22 · 2020: 15 · 2019: 23 · 2018: 12 · 2017: 16 · 2016: 12 · 2015: 11 · 2014: 14 · 2013: 4
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Parkinson s Disease (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- Fondo Nacional de Desarrollo Científico y Tecnológico (1100165)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- dopamine oxidation, aminochrome, neuromelanin, autophagy dysfunction, dopaminergic neurons, chaperone-mediated autophagy, mitochondrial dysfunction, oxidative stress, neuroinflammation, protein degradation, lysosome fusion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.